Brief: Theseus Pharma, On Oct 27, Provided Written Notice To Ariad Pharma Of Its Termination Of License Agreement, Dated June 13, 2018
31/10/2023 20:32
Oct 31 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS-ON OCT 27, PROVIDED WRITTEN NOTICE
TO
ARIAD PHARMACEUTICALS INC OF ITS TERMINATION OF LICENSE
AGREEMENT, DATED JUNE 13, 2018
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7